Director TitleAgeSince
Chairman - -
Chairman - 2012-06-27
Director/Board Member - 2012-12-23
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
+0.21%-7.67%+61.07%+71.32% 68.92B
+1.66%-9.54%+10.39%+60.04% 51.9B
+3.14%+4.61%+15.36%+44.42% 48.73B
+3.45%+5.01%+32.37%+35.96% 43.13B
-2.20%-5.78%+298.44%+532.76% 41.48B
+6.43%+2.76%+16.56%+109.23% 39.96B
+1.28%-0.76%+12.67%+45.10% 30.6B
-2.21%-14.22%+40.33%-0.94% 26.01B
+1.74%-5.30%-12.09%-12.92% 22.27B
Average +1.48%-3.90%+52.79%+98.33% 41.44B
Weighted average by Cap. +1.58%-3.49%+56.57%+105.30%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock